Stock EVFM EVOFEM BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Evofem Biosciences, Inc.

Equities

EVFM

US30048L3024

Delayed OTC Markets
Other stock markets
 10:50:23 2024-05-06 am EDT 		5-day change 1st Jan Change
0.012 USD 0.00% Intraday chart for Evofem Biosciences, Inc. -20.95% -81.72%
Mar. 27 Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 27 Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Evolution of the average Target Price on Evofem Biosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d6a25fd8d8.afeR_6scLfUPr3HawsHTvbkX891GoRtLBWB-Q3u9Gh4.LMbjleIxeZxd2Um0qov-_-YunZEqzUInXVA7FiHefXwGksGPzUZFmkjOHg~d97c537b3d0e8dec9085c43ac488921b

Analyst Recommendations on Evofem Biosciences, Inc.

Laidlaw Downgrades Evofem Biosciences to Hold From Buy MT
Stifel Downgrades Evofem Biosciences to Hold From Buy, Adjusts Price Target to $0.50 From $3 MT
HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $2, Reiterates Buy Rating MT
Morgan Stanley Adjusts Price Target for Evofem Biosciences to $0.75 From $2, Maintains Underweight Rating MT
Laidlaw & Co. Initiates Evofem Biosciences at Buy with $3.50 Price Target MT
Piper Sandler Adjusts Price Target on Evofem Biosciences to $2 From $30, Reiterates Overweight Rating MT
Wall Street Set for Gains as China Rate Cut Boosts Sentiment MT
Morgan Stanley Lowers Evofem Biosciences Price Target to $2 From $8.55, Maintains Underweight Rating MT
EVOFEM BIOSCIENCES : HC Wainwright Adjusts Evofem Biosciences' Price Target to $2.50 from $4, Keeps Buy Rating MT
EVOFEM BIOSCIENCES : Morgan Stanley Downgrades Evofem Biosciences to Underweight Rating From Equal-Weight, Lowers PT to $0.80 From $1 MT
EVOFEM BIOSCIENCES : Morgan Stanley Adjusts Price Target on Evofem Biosciences to $1 From $3, Maintains Equal-Weight Rating MT
EVOFEM BIOSCIENCES : HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $7, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.012
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Evofem Biosciences, Inc.

Laidlaw & Co.
Stifel Nicolaus
HC Wainwright
Morgan Stanley
Piper Sandler

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EVFM Stock
  4. Consensus Evofem Biosciences, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW